TipRanks
Takeda Pharmaceutical Company (DE:TKDA)
FRANKFURT:TKDA
Germany Market
TKDA
Takeda Pharmaceutical Company
RESEARCH TOOLSreports

Takeda Pharmaceutical Company (TKDA) Stock News & Sentiment

4 Followers
Takeda’s Mobocertinib Trial Update: What Lung Cancer Data Mean for TAK Investors
Premium
Company Announcements
Takeda’s Mobocertinib Trial Update: What Lung Cancer Data Mean for TAK Investors
3d ago
TAK
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
Premium
Company Announcements
Takeda Advances Pediatric Vedolizumab Trial, Strengthening Its IBD Growth Story
22d ago
TAK
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
Premium
Company Announcements
Takeda’s CDPATH™ Study Signals Growing Focus on Data‑Driven Crohn’s Care
23d ago
TAK
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
25d ago
AZN
MRK
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
Premium
Company Announcements
Takeda’s GATTEX Safety Survey Update: What Investors Should Watch
26d ago
TAK
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
Premium
Company Announcements
Takeda Refines VPRIV Home Infusion Playbook With New EU Survey
1M ago
TAK
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
Premium
Company Announcements
Takeda’s OBIZUR Surveillance Study: Real World Data That Could Steady TAK’s Growth
2M ago
TAK
More DE:TKDA News >

TKDA News on the Web

Takeda's Zasocitinib Shows Superior Skin Clearance In Phase 3 Psoriasis Trial
rttnews
Bullish
Innovent Expands Phase 3 IBI363 Study To Non-Squamous Lung Cancer; Stock Down
rttnews
Bullish
Innovent Biologics announces expansion of global Phase 3 MarsLight-11 trial
TipRanks News
Neutral
Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
Zacks
Neutral
Takeda announces FDA acceptance of zasocitinib under priority review
TipRanks News
Bullish
Morgan Stanley Remains a Buy on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Bullish
Protagonist Therapeutics price target raised to $190 from $178 at BMO Capital
TipRanks News
Neutral
Inventiva Names Chris Benecchi As COO Ahead Of Lanifibranor's Phase 3 Readout
rttnews
Neutral

News Score - Last 7 Days

Very Positive
DE:TKDA
Sector Average
Media Buzz
This Week6 articles
Weekly Average5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:TKDA’s Media Buzz Sentiment?
6 articles about DE:TKDA were published this week. In an average week, 5 articles are published.
    What is DE:TKDA’s weekly average amount of articles?
    In an average week, 5 articles about DE:TKDA are published.
      What is DE:TKDA’s News Sentiment?
      100% of articles about DE:TKDA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week